The use of significant reduction rates to evaluate health education methods for pregnant smokers: A new harm reduction behavioral indicator?

Health Education and Behavior

Volumn 26, Issue 5, 1999, Pages 648-662

  Windsor, Richard A ^a,e   Li, Chang Qing ^b   Boyd Jr , Neal Richard ^c   Hartmann, Katherine E ^d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Personal Improvement Comp Syst I   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARBON MONOXIDE; COTININE; THIOCYANIC ACID DERIVATIVE;

ADULT; ARTICLE; BIRTH WEIGHT; BOOK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOSE RESPONSE; ECONOMICS; FEMALE; HEALTH EDUCATION; HUMAN; MEDICAID; METABOLISM; METHODOLOGY; MULTICENTER STUDY; NEWBORN; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY COMPLICATION; RANDOMIZED CONTROLLED TRIAL; SMOKING; STATISTICS; UNITED STATES;

ADULT; ALABAMA; BIOLOGICAL MARKERS; BIRTH WEIGHT; CARBON MONOXIDE; COST-BENEFIT ANALYSIS; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH EDUCATION; HUMANS; INFANT, NEWBORN; MANUALS; MEDICAID; NORTH CAROLINA; OUTCOME ASSESSMENT (HEALTH CARE); PREGNANCY; PREGNANCY COMPLICATIONS; SMOKING; THIOCYANATES; UNITED STATES;

EID: 0033211479     PISSN: 10901981     EISSN: None     Source Type: Journal    
DOI: 10.1177/109019819902600506     Document Type: Article

References (40)

1. Behavioral Biology Research Center at The Johns Hopkins University School of Medicine and the Society for Research on Nicotine and Tobacco: Proceedings of a national conference, "Smoking Cessation: Alternative Strategies." Tobacco Control 4(Suppl. 2), 1995.
2. Henningfield J: Introduction to tobacco harm reduction as a complementary strategy to smoking cessation. Tobacco Control 4:S25-S28, 1995.
3. Hughes J: Applying harm reduction to smoking. Tobacco Control 4:S33-S38, 1995.
4. Windsor R, Cutter G, Morris J, et al: The effectiveness of smoking cessation methods for pregnant smokers in public health maternity clinics. Am J Public Health 75:1389-1392, 1985.
5. Windsor R, Warner K, Cutter G: A cost-effectiveness analysis of self-help smoking cessation methods for pregnant women. Public Health Rep 103:83-88, 1988.
6. Windsor R, Lowe J, Perkins L, Smith-Yoder D, Artz L, Crawford M, Amburgy K, Boyd N: Health education methods for pregnant smokers: Its behavioral impact and cost benefit. Am J Public Health 83:201-206, 1993.
7. Hartmann K, Thorp J, Pahel-Short L, Koch M: A randomized controlled trial of smoking cessation intervention in pregnancy in an academic clinic. Obstetr Gynecol 87:621-626, 1996.
8. Li CQ, Windsor R, Perkins L, Goldenberg R, Lowe J: The impact on birthweight and gestational age of cotinine validated smoking reduction during pregnancy. JAMA 269:1519-1524, 1993.
9. Institute of Medicine: Preventing Low Birthweight. Washington, DC, National Academy Press, 1985.
10. U.S. Department of Health and Human Services: Reducing the Health Consequences of Smoking: 25 Years of Progress - A Report of the Surgeon General, 1988 (DHHS Publication No. [CDC] 89-8411). Washington, DC, Government Printing Office, 1989.
11. Mathai M, Skinner A, Lawton K, Weindling A: Maternal smoking, urinary cotinine levels, and birthweight. Aust NZ J Obstetr Gynaecol 30:33-37, 1990.
12. Live births by race of mother [Table 4]. Monthly Vital Statistics Report 46(1[S]2):12, 1997. (U.S. Department of Health and Human Services)
13. Cadell D, et al: National Pregnancy and Health Survey: Drug Use Among Women Delivering Live Births (NIDA-NIH Publication No. 96-3819). Washington, DC, Government Printing Office, 1996.
14. Windsor R, Orleans C: Guidelines and methodological standards for smoking cessation intervention research among pregnant women: Improving the science and art. Health Educ Q 83:131-161, 1986.
15. Dolan Mullen P, Ramirez G, Groff J: A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstetr Gynecol 171:1328-1334, 1994.
16. Windsor R, Boyd N, Orleans C: A meta-evaluation of smoking cessation intervention research among pregnant women: Improving the science and art of obstetrical care practice. Health Educ Res 13:419-438, 1998.
17. Windsor R: A Pregnant Woman's Guide to Quit Smoking (5th ed.). Homewood, AL, Health Promotion Group, 1997. (1-20 review copies = $6.00 per book)
18. Borgers D, Junge B: Thiocyanate as an indicator of tobacco smoke. Prev Med 4:21-30, 1979.
19. Prue D: A critical evaluation of thiocyanate as a biochemical index of smoking exposure. Behav Ther 11:368-379, 1980.
20. Windsor R, Morris J, Cutter G, Higganbottom J, Konkol L: Sensitivity, specificity, and positive predictive value of SCN among pregnant women. Addict Behav 14:447-452, 1989.
21. Etzel R: A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Prev Med 19:190-197, 1990.
22. Boyd N, Windsor R: Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women in public health maternity clinics. J Maternal Child Health 2(2):77-83, 1999.
23. Sexton M, Hebel R: A clinical trial of change in maternal smoking and its effect on birthweight. JAMA 251:911-915, 1984.
24. Hebel R, Fox N, Sexton M: Dose-response of birthweight to various measures of maternal smoking during pregnancy. J Clin Epidemiol 41:483-489, 1988.
25. Seeker-Walker R, Vacek P, Flynn B, Mead P: Smoking in pregnancy, exhaled carbon monoxide, and birthweight. Obstetr Gynecol 89:648-653, 1997.
26. Fiore M: The new vital sign: Assessing and documenting smoking status. JAMA 266:3183-3184, 1991.
27. Windsor R: The Handbook to Plan, Implement, and Evaluate Smoking Cessation Programs for Pregnant Women. White Plains, NY, March of Dimes Foundation, 1990.
28. Fiore M, Bailey W, Cohen S: Smoking Cessation (Clinical Practice Guideline No. 18, AHCPR Publication No. 96-0692). Rockville, MD, U.S. Department of Health and Human Services, 1996.
29. Ershoff D, Quinn V, Mullen P, Lairson P: Pregnancy and medical cost outcomes of a self-help prenatal smoking cessation program in an HMO. Public Health Rep 105:340-347, 1990.
30. Marks J, Koplan J, Hogue C, Dalmat M: A cost-benefit/cost-effectiveness analysis of smoking cessation for pregnant women. Am J Prev Med 6:282-289, 1990.
31. Li CQ, Windsor R, Lowe J, Goldenberg R: Evaluation of the impact of dissemination of smoking cessation methods on the low birthweight rate and health care costs in the U.S.: Achieving the year 2000 infant health objectives. Am J Prev Med 8(3):171-177, 1992.
32. Windsor R, Li CQ, Lowe J, et al: The dissemination of smoking cessation methods for pregnant women: Achieving the year 2000 objectives. Am J Public Health 83:173-178, 1993.
33. Shipp M, Croughan-Minihane M, Petitti D, Washington A: Estimation of the break-even point for smoking cessation programs in pregnancy. Am J Public Health 82:383-390, 1992.
34. Division of Reproductive Health: Common Measures for Evaluation of Smoking Cessation Methods for Pregnant Women (working group report). Atlanta, GA, Centers for Disease Control and Prevention, 1997.
35. Benowitz N: Nicotine replacement therapy during pregnancy. JAMA 266:3174-3177, 1991.
36. Marlatt G: Harm reduction: Come as you are. Addict Behav 21:779-788, 1996.
37. Fagerström K, Tejding R, Westin Å, Lunell E: Aiding reduction of smoking with nicotine replacement medications: Hope for the recalcitrant smoker? Tobacco Control 6:311-316, 1997.
38. Jiménez-Ruiz C, Kunze M, Fagerström K: Nicotine replacement: A new approach to reducing tobacco-related harm. Eur Respir J 6:473-479, 1988.
39. Oncken C, Hatsukami D, Lupo V, Lando H: Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther 59:654-661, 1996.
40. Slotkin T: The impact of fetal nicotine exposure on nervous system development and its role in sudden infant death syndrome, in Benowitz NL (ed.): Nicotine Safety and Toxicity. New York Oxford Press, 1998.